VVM
Versant Venture Management’s Aligos Therapeutics ALGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,457,937
| Closed | -$510K | – | 7 |
|
|
2024
Q2 | $510K | Sell |
1,457,937
-862,444
| -37% | -$302K | 0.66% | 8 |
|
|
2024
Q1 | $2.27M | Hold |
2,320,381
| – | – | 2.2% | 7 |
|
|
2023
Q4 | $1.54M | Hold |
2,320,381
| – | – | 0.4% | 7 |
|
|
2023
Q3 | $1.73M | Hold |
2,320,381
| – | – | 0.92% | 7 |
|
|
2023
Q2 | $2.25M | Hold |
2,320,381
| – | – | 2.67% | 7 |
|
|
2023
Q1 | $2.03M | Hold |
2,320,381
| – | – | 4.23% | 6 |
|
|
2022
Q4 | $2.21M | Hold |
2,320,381
| – | – | 4.58% | 6 |
|
|
2022
Q3 | $2.55M | Hold |
2,320,381
| – | – | 4.35% | 5 |
|
|
2022
Q2 | $2.81M | Hold |
2,320,381
| – | – | 4.3% | 6 |
|
|
2022
Q1 | $4.99M | Hold |
2,320,381
| – | – | 4.98% | 8 |
|
|
2021
Q4 | $27.5M | Hold |
2,320,381
| – | – | 14.73% | 4 |
|
|
2021
Q3 | $36M | Hold |
2,320,381
| – | – | 14.9% | 4 |
|
|
2021
Q2 | $47.3M | Sell |
2,320,381
-971,958
| -30% | -$19.8M | 15.67% | 3 |
|
|
2021
Q1 | $74.9M | Hold |
3,292,339
| – | – | 14.59% | 3 |
|
|
2020
Q4 | $91M | Buy |
+3,292,339
| New | +$91M | 9.45% | 3 |
|